{"url_path":"/sec/nerv/8-k/2026-06-04/item-9-01","section_key":"item-9-01","section_title":"Item 9.01 Financial Statements and Exhibits.","topic":"sec","document":{"doc_type":"8-K","doc_date":"2026-06-04","source_url":"https://www.sec.gov/Archives/edgar/data/1598646/0001193125-26-257379-index.html","accession_number":"0001193125-26-257379","cik":"0001598646","ticker":"NERV","issuer_name":"Minerva Neurosciences, Inc.","edgar_url":"https://www.sec.gov/Archives/edgar/data/1598646/0001193125-26-257379-index.html","primary_entity_key":"0001598646","primary_entity_name":"Minerva Neurosciences, Inc."},"word_count":98,"has_tables":true,"body_markdown":"Item 9.01\n\nFinancial Statements and Exhibits.\n\n(d)  Exhibits.\n\n \n\nExhibit\nNo.\n\n  \n\nDescription\n\n3.1\n  \n[Certificate of Amendment to Amended and Restated Certificate of Incorporation of Minerva Neurosciences, Inc., effective June 4, 2026](d57321dex31.htm)\n\n3.2\n  \n[Amended and Restated Bylaws of Minerva Neurosciences, Inc.](d57321dex32.htm)\n\n104\n  \nCover Page Interactive Data File (embedded within the Inline XBRL document)\n\nSIGNATURES\n\nPursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.\n\n \n\n \n\n \nMINERVA NEUROSCIENCES, INC.\n\nDate: June 4, 2026\n \n\n \nBy:\n \n\n/s/ Frederick Ahlholm\n\n \n\n \n\n \nFrederick Ahlholm\n\n \n\n \n\n \nChief Financial Officer"}